COMPARISON OF APPROVAL DATES OF NEW SUBSTANCES BETWEEN THE UNITED STATES OF AMERICA (FOOD AND DRUG ADMINISTRATION, FDA) AND EUROPE (EUROPEAN MEDICINES AGENCY, EMA)

被引：0
|
作者：
Batscheider, A. [1 ]
Weiss, K. [2 ]
Schnauffer, D. [3 ]
Al-Khalaf, A. [3 ]
Greiner, R. A. [3 ]
Shlaen, E. [3 ]
机构：
[1] IQVIA Commercial GmbH & Co OHG, Munich, BY, Germany
[2] IQVIA Commercial GmbH & Co OHG, Munich, Bavaria, Germany
[3] IQVIA Commercial GmbH & Co OHG, Munich, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PT25
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 48 条
  • [41] Comparison of published core outcome sets with outcomes recommended in regulatory guidance from the US Food and Drug Administration and European Medicines Agency: cross sectional analysis
    Saldanha, Ian J.
    Dodd, Susanna
    Fish, Rebecca
    Gorst, Sarah L.
    Hall, Deborah A.
    Jacobsen, Pamela
    Kirkham, Jamie J.
    Trepel, Dominic
    Williamson, Paula R.
    BMJ MEDICINE, 2022, 1 (01):
  • [42] COMPARISON BETWEEN GUIDELINES ON STABILITY-TESTS FOR ACTIVE SUBSTANCES AND FINISHED PRODUCTS ISSUED BY THE EUROPEAN-COMMUNITY AND THE UNITED-STATES-OF-AMERICA
    VANDENAKKER, CR
    PHARMAZEUTISCHE INDUSTRIE, 1991, 53 (05): : 483 - 489
  • [43] A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration
    Rohr, Ulrich-P.
    Iovino, Mario
    Rudofsky, Leonie
    Li, Qiyu
    Juritz, Stephanie
    Gircys, Arunas
    Wildner, Oliver
    Bujar, Magda
    Bolte, Claus
    di Sanguinetto, Simon Dalla Torre
    Wolfer, Anita
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (09): : 1569 - 1581
  • [44] Reported infections after human tissue transplantation before and after new food and drug administration (FDA) regulations, United States, 2001 through June, 2010
    Tarun K. Mallick
    Alexis Mosquera
    Craig E. Zinderman
    Laura St. Martin
    Robert P. Wise
    Cell and Tissue Banking, 2012, 13 : 259 - 267
  • [45] Reported infections after human tissue transplantation before and after new food and drug administration (FDA) regulations, United States, 2001 through June, 2010
    Mallick, Tarun K.
    Mosquera, Alexis
    Zinderman, Craig E.
    Martin, Laura St.
    Wise, Robert P.
    CELL AND TISSUE BANKING, 2012, 13 (02) : 259 - 267
  • [46] Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020
    Outterson, Kevin
    Orubu, Ebiowei S. F.
    Rex, John
    Ardal, Christine
    Zaman, Muhammad H.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (07) : 1183 - 1190
  • [47] Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) in clinical trials supporting US Food and Drug Administration (FDA) approval of orphan vs. non-orphan drugs
    Molto Valiente, C.
    Tibau, A.
    Ocana Fernandez, A.
    Templeton, A.
    del Carpio Huerta, L.
    Del Paggio, J.
    Barnadas, A.
    Booth, C.
    Amir, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
    Kapelios, Chris J.
    Lainscak, Mitja
    Savarese, Gianluigi
    Laroche, Cecile
    Seferovic, Petar
    Ruschitzka, Frank
    Coats, Andrew
    Anker, Stefan D.
    Crespo-Leiro, Maria G.
    Filippatos, Gerasimos
    Piepoli, Massimo F.
    Rosano, Giuseppe
    Zanolla, Luisa
    Aguiar, Carlos
    Murin, Jan
    Leszek, Przemyslaw
    McDonagh, Theresa
    Maggioni, Aldo P.
    Lund, Lars H.
    Auer, J.
    Ablasser, K.
    Fruhwald, F.
    Dolze, T.
    Brandner, K.
    Gstrein, S.
    Poelzl, G.
    Moertl, D.
    Reiter, S.
    Podczeck-Schweighofer, A.
    Muslibegovic, A.
    Vasilj, M.
    Fazlibegovic, E.
    Cesko, M.
    Zelenika, D.
    Palic, B.
    Pravdic, D.
    Cuk, D.
    Vitlianova, K.
    Katova, T.
    Velikov, T.
    Kurteva, T.
    Gatzov, P.
    Kamenova, D.
    Antova, M.
    Sirakova, V.
    Krejci, J.
    Mikolaskova, M.
    Spinar, J.
    Krupicka, J.
    Malek, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (11) : 1383 - 1397
12345